1/19, 7:31 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Valneva SE

Valneva's COVID vaccine neutralizes Omicron

Valneva SE announced on Wednesday that antibodies induced by three doses of Valneva's vaccine candidate against COVID-19 neutralize the Omicron strain, as reported by the company in a statement published on its website.

According to the findings, all study samples (30) showed neutralizing antibodies against the Delta variant, and 26 of them (87%) presented neutralizing antibodies against the Omicron strain. After trading at $30.26 earlier in the session, following the announcement of the study, the company's shares were up 40.68% to $46.10 at 1:29 pm ET.

"We are extremely pleased with these results, which confirm the potential for broad-spectrum protection of our inactivated, adjuvanted whole virus vaccine and its ability to address currently circulating variants of concern," emphasized Juan Carlos Jaramillo, Chief Medical Officer of Valneva.

Baha Breaking the News (BBN) / JGA